Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Azelaic Acid.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Azelaic Acid.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Azelaic Acid.
Advertisement
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Azelaic Acid.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Azelaic Acid.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Azelaic Acid.
Advertisement
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Azelaic Acid.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Azelaic Acid.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Azelaic Acid.
Advertisement
Digoxin
Digoxin may decrease the cardiotoxic activities of Azelaic Acid.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Azelaic Acid.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Azelaic Acid.
Ouabain
Ouabain may decrease the cardiotoxic activities of Azelaic Acid.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Azelaic Acid.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Azelaic Acid.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Azelaic Acid.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Azelaic Acid.
